학술논문

COVID-19 Adverse Outcomes in Immunocompromised Patients.
Document Type
Article
Source
International Journal of Cancer Management; Dec2023, Vol. 16 Issue 1, p1-6, 6p
Subject
HIV-positive persons
INTENSIVE care units
HIV infections
COVID-19
IMMUNOCOMPROMISED patients
CROSS-sectional method
AUTOIMMUNE diseases
PATIENTS
RISK assessment
CANCER patients
SEX distribution
HOSPITAL care
HEMATOLOGIC malignancies
POLYMERASE chain reaction
IMMUNOSUPPRESSIVE agents
TRANSPLANTATION of organs, tissues, etc.
Language
ISSN
25384422
Abstract
Copyright of International Journal of Cancer Management is the property of Medical Journals Commission of the Ministry of Health & Medical Education and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)